To evaluate whether Pyk2 could be detected in FAK-null tumours, we measured Pyk2 levels and activity by immunoblot/immunopreciptation analyses with Pyk2 and phosphotyrosine-specific antisera (Figure S5 in Additional file 5). The gene discussed is PTK2; the disease is neoplasm.